Aligos Therapeutics
Price & Volume
Stats
See more52W Range | $3.76-$46.80 |
Market Cap | $67.2M |
Shares Short | 312,192 |
Financials
See moreRevenue (12 Mos) | $3.1M |
Revenue Growth (YoY) | -9% |
Gross Profit (12 Mos) | -$58.1M |
Diluted EPS | -$13.27 |
News
See moreYahoo Finance • 18 days ago
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
Yahoo Finance • 19 days ago
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • last month
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Aligos begins dosing in phase 2 HBV drug study
About
CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
CFO | Ms. Lesley Ann Calhoun C.P.A. |
Address | One Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
